Wealth Enhancement Advisory Services’s Eli Lilly LLY Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83M	Buy	+1,700	New	+$1.74M	﹤0.01%	1636
2024 Q4	–	Sell	-1,700	Closed	-$72.6K	–	3050
2024 Q3	$72.6K	Buy	1,700 +1,000	+143%	+$899K	﹤0.01%	2594
2024 Q2	$1.04K	Sell	700 -1,000	-59%	-$800K	﹤0.01%	2590
2024 Q1	$13K	Hold	1,700	–	–	﹤0.01%	2399
2023 Q4	$66.9K	Buy	+1,700	New	+$992K	﹤0.01%	2197

Other funds holding LLY

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Wealth Enhancement Advisory Services's LLY Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $22.8M and bringing the position to 183,702 shares worth $197M. The position accounts for 0.33% of the portfolio, ranked #45.

Wealth Enhancement Advisory Services first reported a position in LLY in Q4 2015 and has held it in 34 quarters since. The position peaked at $228M in Q4 2025. 1,103 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Wealth Enhancement Advisory Services held 183,702 shares of Eli Lilly worth $197M as of Q2 2026.
Wealth Enhancement Advisory Services bought 22,314 Eli Lilly shares in Q2 2026, an estimated $22.8M.
Eli Lilly made up 0.33% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #45 holding.
Wealth Enhancement Advisory Services first reported a position in Eli Lilly in Q4 2015 and has held it in 34 quarters since.
Wealth Enhancement Advisory Services's Eli Lilly position peaked at $228M in Q4 2025.
1,103 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.